64.73

0.02% 0.04

Bristol Myers Squibb Co (BMY)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt BMY? Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$64.69

Offen:

$64.57

24-Stunden-Volumen:

779.89K

Relative Volume:

0.07

Marktkapitalisierung:

$132.09B

Einnahmen:

$48.48B

Nettoeinkommen (Verlust:

$7.27B

KGV:

18.17

EPS:

3.5626

Netto-Cashflow:

$11.91B

1W Leistung:

-4.37%

1M Leistung:

-0.03%

6M Leistung:

+6.71%

1J Leistung:

+36.99%

1-Tages-Spanne:

$64.42

$65.05

1-Wochen-Bereich:

$64.39

$68.24

52-Wochen-Spanne:

$42.52

$68.64

Bristol Myers Squibb Co Stock (BMY) Company Profile

Firmenname

Bristol Myers Squibb Co

Sektor

Healthcare (1087)

Branche

Drug Manufacturers - General (20)

Telefon

(609) 252-4621

Adresse

ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NY

Mitarbeiter

32,500

Twitter

@BMSNEWS

Nächster Verdiensttermin

2026-10-29

Neueste SEC-Einreichungen

BMY's Discussions on Twitter

Compare BMY vs LLY, JNJ, ABBV, MRK, NVS

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BMY Bristol Myers Squibb Co	64.67	132.14B	48.48B	7.27B	11.91B	3.5626
LLY Lilly Eli Co	1,130.76	1.00T	72.25B	25.28B	10.37B	27.78
JNJ Johnson Johnson	269.04	648.55B	97.93B	21.04B	17.80B	8.6278
ABBV Abbvie Inc	248.61	439.62B	62.82B	3.60B	19.98B	2.0274
MRK Merck Co Inc	147.72	366.28B	65.51B	8.93B	14.12B	3.5532
NVS Novartis Ag Adr	138.83	261.73B	54.66B	13.58B	16.05B	7.0171

Bristol Myers Squibb Co Stock (BMY) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-02-25	Eingeleitet	RBC Capital Mkts	Sector Perform
2026-02-20	Eingeleitet	Barclays	Overweight
2026-01-07	Hochstufung	UBS	Neutral → Buy
2025-12-15	Hochstufung	BofA Securities	Neutral → Buy
2025-12-12	Hochstufung	Guggenheim	Neutral → Buy
2025-11-13	Eingeleitet	Scotiabank	Sector Perform
2025-08-05	Herabstufung	Daiwa Securities	Outperform → Neutral
2025-04-22	Eingeleitet	Cantor Fitzgerald	Neutral
2025-04-22	Eingeleitet	Piper Sandler	Overweight
2024-12-16	Hochstufung	Jefferies	Hold → Buy
2024-12-10	Fortgesetzt	BofA Securities	Neutral
2024-11-15	Eingeleitet	Wolfe Research	Peer Perform
2024-11-13	Hochstufung	Daiwa Securities	Neutral → Outperform
2024-11-12	Hochstufung	Leerink Partners	Market Perform → Outperform
2024-10-25	Herabstufung	Citigroup	Buy → Neutral
2024-10-17	Eingeleitet	Bernstein	Mkt Perform
2024-07-29	Herabstufung	Barclays	Overweight → Equal Weight
2024-03-11	Herabstufung	Societe Generale	Buy → Hold
2024-02-06	Herabstufung	Redburn Atlantic	Buy → Neutral
2024-01-03	Herabstufung	BofA Securities	Buy → Neutral
2023-11-15	Herabstufung	Cantor Fitzgerald	Overweight → Neutral
2023-11-09	Eingeleitet	Deutsche Bank	Hold
2023-11-02	Herabstufung	Daiwa Securities	Outperform → Neutral
2023-10-27	Herabstufung	BMO Capital Markets	Outperform → Market Perform
2023-10-27	Hochstufung	HSBC Securities	Reduce → Hold
2023-10-27	Herabstufung	William Blair	Outperform → Mkt Perform
2023-10-20	Fortgesetzt	UBS	Neutral
2023-07-14	Eingeleitet	HSBC Securities	Reduce
2023-07-10	Eingeleitet	SVB Securities	Market Perform
2023-06-28	Eingeleitet	Daiwa Securities	Outperform
2023-03-06	Eingeleitet	Jefferies	Hold
2023-01-17	Eingeleitet	Cantor Fitzgerald	Overweight
2022-11-18	Eingeleitet	Credit Suisse	Neutral
2022-10-10	Herabstufung	Guggenheim	Buy → Neutral
2022-09-14	Herabstufung	Berenberg	Buy → Hold
2022-06-03	Herabstufung	Raymond James	Outperform → Mkt Perform
2022-04-06	Fortgesetzt	Morgan Stanley	Underweight
2021-12-17	Eingeleitet	Goldman	Buy
2021-12-09	Fortgesetzt	Wells Fargo	Equal Weight
2021-11-19	Eingeleitet	BMO Capital Markets	Outperform
2021-11-01	Herabstufung	Argus	Buy → Hold
2021-07-27	Fortgesetzt	Truist	Buy
2021-04-30	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2021-04-13	Hochstufung	Truist	Hold → Buy
2020-11-16	Hochstufung	Societe Generale	Hold → Buy
2020-11-10	Fortgesetzt	Bernstein	Mkt Perform
2020-11-06	Herabstufung	Gabelli & Co	Buy → Hold
2020-10-19	Hochstufung	Guggenheim	Neutral → Buy
2020-09-29	Eingeleitet	Berenberg	Buy
2020-07-28	Eingeleitet	Raymond James	Outperform
2020-04-02	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2020-03-23	Herabstufung	Societe Generale	Buy → Hold
2020-02-27	Eingeleitet	Barclays	Equal Weight
2020-01-06	Fortgesetzt	Citigroup	Buy
2019-12-13	Hochstufung	Argus	Hold → Buy
2019-11-22	Fortgesetzt	Morgan Stanley	Equal-Weight
2019-10-17	Fortgesetzt	BofA/Merrill	Buy
2019-08-14	Hochstufung	Atlantic Equities	Neutral → Overweight
2019-05-28	Eingeleitet	Goldman	Buy
2019-05-20	Herabstufung	Argus	Buy → Hold
2019-05-03	Hochstufung	Barclays	Equal Weight → Overweight
2019-05-03	Fortgesetzt	JP Morgan	Overweight
2019-01-15	Hochstufung	Societe Generale	Sell → Buy
2018-10-22	Herabstufung	Citigroup	Buy → Neutral

Alle ansehen

Bristol Myers Squibb Co Aktie (BMY) Neueste Nachrichten

08:18 AM

What macro factors could move Bristol Myers Squibb (NYSE:BMY) shares this week? - Kalkine Media

08:18 AM

08:13 AM

National Coalition of Pharmaceutical Industry, Academic, and Nonprofit Partners Launches Fifth Winn CIPP Cohort - Finviz

08:13 AM

05:50 AM

SOTYKTU Clinical, Regulatory and Commercial Intelligence Report 2026 - GlobeNewswire Inc.

05:50 AM

05:49 AM

Bristol Myers Squibb Company $BMY Shares Purchased by Waverly Advisors LLC - MarketBeat

05:49 AM

03:00 AM

CD&R Taps Former Bristol-Myers CEO Caforio in Healthcare Push - Bloomberg.com

03:00 AM

12:01 PM

Bristol-Myers Squibb stock heads into the open after a 3.2% drop - AD HOC NEWS

12:01 PM

Sep 08, 2026